AB-2004

Axial Biotherapeutics Doses First Patient in Ph Ib/IIa Trial of AB-2004 for Treatment of Autism Related GI Dysfunction and Behavioral Symptoms
CP Wire
Thu, 07/18/19 - 02:21 pm
Axial Biotherapeutics
AB-2004
microbiome
autism